Cargando…

Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report

INTRODUCTION: Leukocytoclastic vasculitis (also known as hypersensitivity vasculitis and cutaneous necrotizing vasculitis) can present with various manifestations, which often delays the diagnosis and treatment. In order to show the importance of the early recognition of leukocytoclastic vasculitis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Keri, Martin, Jeanine, Zito, Susan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906497/
https://www.ncbi.nlm.nih.gov/pubmed/20594300
http://dx.doi.org/10.1186/1752-1947-4-204
_version_ 1782184038622035968
author Brown, Keri
Martin, Jeanine
Zito, Susan
author_facet Brown, Keri
Martin, Jeanine
Zito, Susan
author_sort Brown, Keri
collection PubMed
description INTRODUCTION: Leukocytoclastic vasculitis (also known as hypersensitivity vasculitis and cutaneous necrotizing vasculitis) can present with various manifestations, which often delays the diagnosis and treatment. In order to show the importance of the early recognition of leukocytoclastic vasculitis, we present a case which occurred secondary to the use of a common pharmaceutical, naproxen. We were unable to find a case of leukocytoclastic vasculitis secondary to naproxen in the literature. CASE PRESENTATION: We present the case of a 33-year-old African American woman with below the knee and bilateral digital gangrene from hypersensitivity vasculitis secondary to the non-steroidal anti-inflammatory medication naproxen. CONCLUSION: This is an original case report focusing on the rheumatologic management of leukocytoclastic vasculitis. However, other specialties, such as internal medicine, dermatology, infectious disease, general surgery and pathology, can gain valuable information by reviewing this case report. Reporting a case of leukocytoclastic vasculitis secondary to treatment with naproxen will advance our understanding of this disease etiology by adding yet another non-steroidal anti-inflammatory drug to the list of potential causes of leukocytoclastic vasculitis.
format Text
id pubmed-2906497
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29064972010-07-20 Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report Brown, Keri Martin, Jeanine Zito, Susan J Med Case Reports Case Report INTRODUCTION: Leukocytoclastic vasculitis (also known as hypersensitivity vasculitis and cutaneous necrotizing vasculitis) can present with various manifestations, which often delays the diagnosis and treatment. In order to show the importance of the early recognition of leukocytoclastic vasculitis, we present a case which occurred secondary to the use of a common pharmaceutical, naproxen. We were unable to find a case of leukocytoclastic vasculitis secondary to naproxen in the literature. CASE PRESENTATION: We present the case of a 33-year-old African American woman with below the knee and bilateral digital gangrene from hypersensitivity vasculitis secondary to the non-steroidal anti-inflammatory medication naproxen. CONCLUSION: This is an original case report focusing on the rheumatologic management of leukocytoclastic vasculitis. However, other specialties, such as internal medicine, dermatology, infectious disease, general surgery and pathology, can gain valuable information by reviewing this case report. Reporting a case of leukocytoclastic vasculitis secondary to treatment with naproxen will advance our understanding of this disease etiology by adding yet another non-steroidal anti-inflammatory drug to the list of potential causes of leukocytoclastic vasculitis. BioMed Central 2010-07-01 /pmc/articles/PMC2906497/ /pubmed/20594300 http://dx.doi.org/10.1186/1752-1947-4-204 Text en Copyright ©2010 Brown et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Brown, Keri
Martin, Jeanine
Zito, Susan
Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title_full Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title_fullStr Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title_full_unstemmed Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title_short Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
title_sort severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906497/
https://www.ncbi.nlm.nih.gov/pubmed/20594300
http://dx.doi.org/10.1186/1752-1947-4-204
work_keys_str_mv AT brownkeri severeleukocytoclasticvasculitissecondarytotheuseofanaproxenandrequiringamputationacasereport
AT martinjeanine severeleukocytoclasticvasculitissecondarytotheuseofanaproxenandrequiringamputationacasereport
AT zitosusan severeleukocytoclasticvasculitissecondarytotheuseofanaproxenandrequiringamputationacasereport